Sotac Pharmaceuticals Limited (NSE:SOTAC)
India flag India · Delayed Price · Currency is INR
90.05
0.00 (0.00%)
Oct 1, 2026, 2:34 PM IST

Sotac Pharmaceuticals Company Description

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India.

Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (IP-lactams and non-IP-lactams), anti-fungal, and cephalosporin products.

The company also offers non-beta lactam general tablets, beta lactam coated tablets, beta lactam uncoated tablets, non-beta lactam general capsules, beta‐lactam capsules, oral liquid, and dry syrup and external preparations such as nasal spray, and relief spray and creams, as well as manufactures nutraceuticals and food products.

It also exports its products. Sotac Pharmaceuticals Limited was founded in 2014 and is based in Ahmedabad, India.

Sotac Pharmaceuticals Limited
CountryIndia
Founded2014
IndustryMedical - Pharmaceuticals
SectorHealthcare
Employees55
CEOSharadkumar Patel

Contact Details

Address:
Plot No. PF-21 & PF-22/A
Ahmedabad, 382110
India
Phone91 99 1356 2852
Websitesotacpharma.com

Stock Details

Ticker SymbolSOTAC
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE0O2D01012
SIC Code2834

Key Executives

NamePosition
Sharadkumar PatelChief Executive Officer
Brijeshkumar PatelChief Financial Officer
Pankaj MahabaleshwarkarChief Operating Officer